Your browser is no longer supported. Please, upgrade your browser.
PCRX [NASD]
Pacira BioSciences, Inc.
Index- P/E26.21 EPS (ttm)2.84 Insider Own0.70% Shs Outstand42.93M Perf Week0.05%
Market Cap3.17B Forward P/E21.28 EPS next Y3.50 Insider Trans-49.45% Shs Float40.45M Perf Month8.54%
Income126.10M PEG0.87 EPS next Q0.81 Inst Own- Short Float14.67% Perf Quarter16.47%
Sales421.10M P/S7.53 EPS this Y26.90% Inst Trans4.50% Short Ratio12.03 Perf Half Y23.40%
Book/sh13.62 P/B5.47 EPS next Y64.66% ROA13.50% Target Price74.15 Perf Year64.93%
Cash/sh12.49 P/C5.96 EPS next 5Y30.00% ROE29.60% 52W Range27.46 - 79.98 Perf YTD24.42%
Dividend- P/FCF111.70 EPS past 5Y7.30% ROI1.50% 52W High-6.91% Beta1.16
Dividend %- Quick Ratio6.80 Sales past 5Y16.30% Gross Margin72.90% 52W Low171.12% ATR3.82
Employees606 Current Ratio7.60 Sales Q/Q12.20% Oper. Margin5.00% RSI (14)53.28 Volatility5.62% 5.29%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin30.00% Rel Volume1.30 Prev Close78.82
ShortableYes LT Debt/Eq0.78 EarningsFeb 25 BMO Payout0.00% Avg Volume493.14K Price74.45
Recom2.30 SMA201.13% SMA509.09% SMA20027.57% Volume639,186 Change-5.54%
Feb-11-21Downgrade Northland Capital Outperform → Market Perform $72 → $75
Jan-21-21Downgrade SVB Leerink Outperform → Mkt Perform $75
Sep-21-20Upgrade Northland Capital Market Perform → Outperform $58 → $67
Jul-06-20Reiterated Needham Buy $52 → $64
May-27-20Initiated Guggenheim Neutral
Apr-07-20Initiated Northland Capital Outperform $50
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $44
Feb-24-20Reiterated H.C. Wainwright Buy $60 → $63
Jan-24-20Initiated SunTrust Buy
Jan-23-20Initiated SunTrust Buy
Nov-06-19Initiated BTIG Research Buy $56
Jun-11-19Initiated Barclays Overweight $52
May-06-19Upgrade Mizuho Underperform → Neutral $29 → $38
May-02-19Upgrade Stifel Sell → Hold $45
Feb-01-19Downgrade Mizuho Neutral → Underperform
Aug-06-18Downgrade BofA/Merrill Buy → Neutral
Apr-09-18Reiterated H.C. Wainwright Buy $45 → $48
Mar-21-18Reiterated Mizuho Neutral $44 → $31
Feb-16-18Downgrade Needham Buy → Hold
Jan-19-18Initiated Seaport Global Securities Buy $50
Feb-25-21 04:01PM  
08:00AM  
06:30AM  
Feb-23-21 02:49PM  
Feb-18-21 07:30AM  
Feb-14-21 01:32PM  
Feb-10-21 07:00AM  
Jan-29-21 03:32AM  
Jan-26-21 03:39PM  
08:00AM  
Jan-15-21 11:40AM  
Jan-12-21 12:48PM  
Jan-08-21 04:18PM  
Jan-07-21 04:10PM  
07:30AM  
Jan-06-21 07:30AM  
Dec-15-20 02:39AM  
Dec-09-20 04:40PM  
07:30AM  
Nov-24-20 07:30AM  
Nov-19-20 10:08AM  
Nov-18-20 07:30AM  
Nov-16-20 01:48PM  
Nov-13-20 10:40AM  
Nov-11-20 01:27PM  
08:00AM  
Nov-10-20 07:30AM  
Nov-09-20 12:42PM  
Oct-30-20 12:57PM  
03:01AM  
Oct-29-20 09:15AM  
08:00AM  
06:30AM  
Oct-22-20 12:33PM  
Oct-21-20 07:30AM  
06:25AM  
Oct-20-20 07:30AM  
Oct-19-20 11:30AM  
Oct-07-20 08:00AM  
Sep-21-20 11:56AM  
Sep-18-20 08:07AM  
Sep-16-20 02:55PM  
Sep-15-20 07:30AM  
Sep-11-20 07:30AM  
Sep-09-20 08:00AM  
Sep-05-20 11:31AM  
Aug-06-20 08:00AM  
Aug-05-20 04:05PM  
07:30AM  
Aug-04-20 07:30AM  
Jul-30-20 07:30AM  
Jul-28-20 05:03PM  
Jul-12-20 12:43PM  
Jul-07-20 07:51PM  
Jul-06-20 04:02PM  
04:01PM  
Jul-02-20 07:30AM  
Jun-29-20 09:00AM  
Jun-16-20 07:30AM  
Jun-10-20 04:36PM  
May-27-20 07:30AM  
May-13-20 07:30AM  
May-07-20 08:00AM  
May-04-20 07:30AM  
Apr-30-20 07:30AM  
Apr-23-20 08:59AM  
Apr-07-20 05:00PM  
Apr-06-20 08:00AM  
Mar-21-20 11:30AM  
Mar-17-20 09:53AM  
Mar-13-20 12:45PM  
11:40AM  
Mar-10-20 10:24AM  
Mar-09-20 07:30AM  
Mar-05-20 07:44AM  
Mar-04-20 09:22AM  
Feb-27-20 12:32AM  
Feb-26-20 12:45PM  
11:40AM  
Feb-23-20 09:46AM  
Feb-21-20 10:22AM  
09:45AM  
Feb-20-20 08:00AM  
Feb-19-20 09:21AM  
Feb-13-20 07:30AM  
Feb-12-20 09:45AM  
Feb-11-20 06:39AM  
Feb-07-20 06:52AM  
Feb-06-20 08:36AM  
08:10AM  
Feb-05-20 08:37AM  
Feb-03-20 08:53AM  
Jan-22-20 08:53AM  
Jan-21-20 09:06AM  
07:30AM  
Jan-13-20 11:40AM  
Jan-09-20 07:30AM  
Jan-08-20 11:16AM  
07:30AM  
Jan-07-20 02:08PM  
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company has collaboration with Aetna. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STACK DAVID MCEO and ChairmanFeb 03Option Exercise10.8121,250229,71397,311Feb 04 07:58 PM
STACK DAVID MCEO and ChairmanFeb 03Sale71.2121,2501,513,25976,061Feb 04 07:58 PM
STACK DAVID MCEO and ChairmanFeb 02Option Exercise10.8121,250229,71397,311Feb 04 07:58 PM
STACK DAVID MCEO and ChairmanFeb 02Sale69.4121,2501,474,87476,061Feb 04 07:58 PM
REINHARDT MAXPresidentJan 06Sale60.811106,68914,000Jan 08 04:39 PM
Brege LauraDirectorNov 16Option Exercise13.9812,000167,76019,921Nov 17 05:39 PM
Brege LauraDirectorNov 16Sale65.9512,000791,4007,921Nov 17 05:39 PM
REINHARDT MAXPresidentNov 13Option Exercise42.5425,0001,063,50039,000Nov 17 05:28 PM
Riker Lauren BullaroVice President, FinanceNov 13Option Exercise10.813,00032,43016,181Nov 17 05:37 PM
WINSTON ROYChief Clinical OfficerNov 13Sale62.005,000310,00034,785Nov 17 05:30 PM
REINHARDT MAXPresidentNov 13Sale63.3825,0001,584,39014,000Nov 17 05:28 PM
Riker Lauren BullaroVice President, FinanceNov 13Sale63.813,000191,43013,181Nov 17 05:37 PM
STACK DAVID MCEO and ChairmanOct 16Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 16Sale55.5630,0001,666,800173,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 15Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 15Sale55.0030,0001,650,000173,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 14Option Exercise10.8130,000324,300203,377Oct 16 04:26 PM
STACK DAVID MCEO and ChairmanOct 14Sale55.5330,0001,665,900173,377Oct 16 04:26 PM
PACE GARY WDirectorSep 25Option Exercise16.6770,0001,166,900129,949Sep 29 05:16 PM
Williams Kristen MarieChief Administrative OfficerSep 17Option Exercise39.1927,8711,092,26852,758Sep 17 07:13 PM
REINHARDT MAXPresidentSep 17Option Exercise42.5425,0001,063,50039,000Sep 21 06:23 PM
REINHARDT MAXPresidentSep 17Sale59.8125,4201,520,31814,000Sep 21 06:23 PM
Williams Kristen MarieChief Administrative OfficerSep 17Sale59.8227,8711,667,29024,887Sep 17 07:13 PM
Williams Kristen MarieChief Administrative OfficerSep 16Option Exercise39.1927,8531,091,56052,740Sep 17 07:13 PM
Riker Lauren BullaroVice President, FinanceSep 16Option Exercise10.813,00032,43016,181Sep 17 07:10 PM
Williams Kristen MarieChief Administrative OfficerSep 16Sale60.1427,8531,675,15024,887Sep 17 07:13 PM
Riker Lauren BullaroVice President, FinanceSep 16Sale60.343,000181,02013,181Sep 17 07:10 PM
Williams Kristen MarieChief Administrative OfficerSep 15Option Exercise39.1927,8531,091,56052,740Sep 17 07:13 PM
Williams Kristen MarieChief Administrative OfficerSep 15Sale59.3927,8531,654,05824,887Sep 17 07:13 PM
Wicki AndreasDirectorSep 09Sale62.022,216137,436692,970Sep 11 08:03 PM
STACK DAVID MCEO and ChairmanAug 17Sale61.9115,000928,619173,377Aug 19 05:44 PM
Wicki AndreasDirectorAug 13Sale61.4734,9042,145,549695,186Aug 13 08:58 PM
Wicki AndreasDirectorAug 12Sale60.82113,5006,903,070730,090Aug 13 08:58 PM
Riker Lauren BullaroVice President, FinanceAug 11Option Exercise10.348,18084,58120,813Aug 13 04:35 PM
Wicki AndreasDirectorAug 11Sale61.32106,7726,546,747843,590Aug 13 08:58 PM
Riker Lauren BullaroVice President, FinanceAug 11Sale60.508,180494,89013,181Aug 13 04:35 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsAug 03Option Exercise44.102,500110,25022,750Aug 05 05:16 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsAug 03Sale52.682,500131,70020,796Aug 05 05:16 PM
STACK DAVID MCEO and ChairmanJul 15Sale56.8812,000682,560188,377Jul 17 05:44 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 29Option Exercise42.0756,2502,366,58880,351Jul 01 09:17 PM
Riker Lauren BullaroVice President, FinanceJun 29Option Exercise10.346,00062,04018,633Jul 01 09:20 PM
Riker Lauren BullaroVice President, FinanceJun 29Sale49.476,000296,80012,633Jul 01 09:20 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 29Sale50.2760,1013,021,31420,250Jul 01 09:17 PM
STACK DAVID MCEO and ChairmanJun 08Sale48.1217,111823,402166,909Jun 08 09:09 PM
Brege LauraDirectorJun 05Sale48.702,100102,2706,661Jun 08 09:04 PM
Riker Lauren BullaroVice President, FinanceJun 05Sale48.371,75284,7447,833Jun 08 09:08 PM
Williams Kristen MarieChief Administrative OfficerJun 05Sale48.615,904286,99310,887Jun 08 09:10 PM
Williams Kristen MarieChief Administrative OfficerJun 04Sale46.332,402111,28716,791Jun 08 09:10 PM
STACK DAVID MCEO and ChairmanJun 04Sale46.3314,314663,182184,020Jun 08 09:09 PM
Riker Lauren BullaroVice President, FinanceJun 04Sale46.3387940,7259,585Jun 08 09:08 PM
McLoughlin DennisChief Commercial OfficerJun 04Sale46.331,44767,04114,898Jun 08 09:07 PM
Reinhart Charles A. IIIChief Financial OfficerJun 04Sale46.331,48968,98714,847Jun 08 09:07 PM
LARANJEIRA CHARLES ANTHONYSVP, Technical OperationsJun 04Sale46.3386339,98410,101Jun 08 09:06 PM
HASTINGS PAUL JDirectorJun 04Sale47.462,02596,1074,856Jun 08 09:05 PM
Riker Lauren BullaroVice President, FinanceMay 21Option Exercise10.342,00020,68012,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 21Sale45.262,00090,52010,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 19Option Exercise10.342,00020,68012,464May 21 07:19 PM
Riker Lauren BullaroVice President, FinanceMay 19Sale42.812,00085,62010,464May 21 07:19 PM
PACE GARY WDirectorMar 12Option Exercise4.4621,73696,84558,689Mar 16 05:54 PM
LONGENECKER JOHN P PHDDirectorMar 12Option Exercise1.613,7366,01516,497Mar 16 05:53 PM
WINSTON ROYChief Clinical OfficerMar 11Buy36.502,50091,25025,237Mar 12 07:18 PM